0001012975-17-000157.txt : 20170223 0001012975-17-000157.hdr.sgml : 20170223 20170223192031 ACCESSION NUMBER: 0001012975-17-000157 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170221 FILED AS OF DATE: 20170223 DATE AS OF CHANGE: 20170223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 38 SIDNEY STREET STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-272-5275 MAIL ADDRESS: STREET 1: 38 SIDNEY STREET STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NELSEN ROBERT CENTRAL INDEX KEY: 0001219042 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 17634290 MAIL ADDRESS: STREET 1: 8755 W. HIGGINS ROAD STREET 2: SUITE 1025 CITY: CHICAGO STATE: IL ZIP: 60631 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-02-21 0001439222 AGIOS PHARMACEUTICALS INC AGIO 0001219042 NELSEN ROBERT C/O ARCH VENTURE PARTNERS 8755 WEST HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 1 0 0 0 Common Stock 2017-02-21 4 S 0 1780 54.1733 D 417265 I By ARCH Venture Fund VII, L.P. Common Stock 2017-02-21 4 S 0 34650 50.5576 D 382615 I By ARCH Venture Fund VII, L.P. Common Stock 2017-02-22 4 S 0 46938 49.9043 D 335677 I By ARCH Venture Fund VII, L.P. Common Stock 2017-02-22 4 S 0 1000 50.3455 D 334677 I By ARCH Venture Fund VII, L.P. Common Stock 2017-02-23 4 S 0 42596 47.727 D 292081 I By ARCH Venture Fund VII, L.P. Common Stock 2017-02-23 4 S 0 8400 48.7478 D 283681 I By ARCH Venture Fund VII, L.P. Common Stock 2016-06-30 4 J 0 25412 A 73078 D Common Stock 2016-08-08 4 J 0 36152 A 109230 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.36. The reporting person undertakes to provide to AGIO, any security holder of AGIO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5) and (6) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $50.74. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.25 to $50.25. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.255 to $50.68. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.50 to $48.24. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.51 to $49.06. These shares are owned directly by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"). The sole general partner of ARCH Fund VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"). The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"). The Managing Directors of ARCH VII LLC, Robert T. Nelsen, Keith Crandell and Clinton Bybee, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by ARCH Fund VII. Each Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of such securities for Section 16 or any other purpose. Distribution of Common Stock held by a limited partnership to its partners for no consideration. Change from indirect to direct ownership of shares previously reported as beneficially owned by the reporting person. /s/ Robert T. Nelsen 2017-02-23